Vesicular stomatitis virus (VSV) forms pseudotypes with envelope components of reticuloendotheliosis virus (REV). The VSV pseudotype possesses the limited host range and antigenic properties of REV. Approximately 70% of the VSV, Indiana serotype, and 45% of VSV, New Jersey serotype, produced from the REV strain T-transformed chicken bone marrow cells contain mixed envelope components of both VSV and REV. VSV pseudotypes with mixed envelope antigens can be neutralized with excess amounts of either anti-VSV antiserum or anti-REV antiserum.
RNA-containing enveloped viruses can mix phenotypically to form pseudotypes with the genomic RNA of one virus and the envelope components of the other. The phenomenon of the phenotypic mixing between two different viruses was demonstrated first by Choppin and Compans (2) for simian virus 5 and vesicular stomatitis virus (VSV). The exchange involves the viral glycoprotein, which is the constituent of the surface projections of the virion, and appears to occur during the budding process on the plasma membrane. Zavada (10) reported that VSV grown in avian myeloblastosis virus (AMV)-infected cells acquired envelope components that conferred the host range of AMV to the virion of VSV. Love and Weiss (9) found that growth of VSV in cells expressing chick cell-associated helper factor coded by an endogenous viral genome yielded pseudotypes with the envelope specificity of the helper factor. The phenomenon of phenotypic mixing between the different viruses has been extended to the interactions between RNA and DNA viruses. Huang et al. (5) found virions containing the RNA genome of VSV in the envelope antigen of herpes simplex virus. Certain combinations of enveloped RNA viruses, however, failed to interact in the mixedly infected cells. Burge and Pfefferkorn (1) failed to detect interactions between SVS and Sindbis virus. Halpern et at. (4) reported that there is no complementation, phenotypic mixing, or genetic recombination between reticuloendotheliosis virus (REV), an avian type C RNA tumor virus (9) , and avian leukosis viruses (ALV).
We were interested in studying the interactions between REV and VSV, since REV has failed to interact with ALVs. REV antigens were observed to interact with the VSV genome to form a VSV pseudotype, and these VSV pseudotypes with REV coats were used to determine whether or not the mammalian cell supports the initial steps of REV infection.
To form pseudotypes of VSV with REV, we used chicken bone marrow (CBM) cells transformed by REV strain T (REV-T), which shed REV-T into the cell-free supernatant (3) VSVIND from CBM cells had a titer of approximately 109 PFU/ml on CEF cells, whereas VSVNJ grown in CBM cells had a titer of approximately 108 PFU/ml. Neutralization of these progeny VSV with rabbit anti-VSV antiserum revealed that approximately 1 in every 30,000 VSVIND plaques was resistant to neutralization by anti-VSVIND antiserum and 1 in every 2,500 VSVNJ plaques-was resistant to neutralization with anti-VSVNJ antiserum (Table  1) . Non-neutralizable VSV plaques represent pseudotypes of VSV consisting of the RNA genome of VSV and pure coat components (glycoprotein peplomers) of REV-T, because the anti-REV-T antiserum neutralizes the residual infectivity, and no VSV plaques are then detecta- Anti-VSVIND + Anti-REV-T <2 0 1.1 x 107 Anti-VSVNJ + Anti-REV-T NT 1.4 x 107 0 a Approximately 1.5 x 108 REV-T producer CBM cells transformed in vivo by REV-T were superinfected with either VSVIND or VSVNJ at a multiplicity of infection of 10 PFU/cell. The infected cells were washed twice with Dulbecco-modified minimal essential medium after 45 min of adsorption and incubated in minimal essential medium containing 50 mM N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid buffer, pH 6.8 (Sigma), and 10% fetal calf serum at 370C in a 5% CO2 in air atmosphere with saturated humidity. After 16 to 17 h, extracellular virus was collected by centrifugation as previously described (6) . Neutralization mixtures were made with undiluted antiserum against different viruses as indicated. Each serum sample was mixed in equal volumes with each virus preparation, and neutralization mixtures were incubated at 370C for 45 min and then diluted. The control virus preparations were treated identically using normal rabbit serum. Virus in triplicate aliquots of 0.2 ml of the appropriate dilutions were adsorbed on monolayers of CEF on 60-mm plastic petri dishes for 45 min at 370C. The infected cells were overlaid with minimal essential medium containing 5% fetal calf serum and 0.9% agar. After incubation at 370C for 24 h in a humidified incubator with 5% C02, the cells were fixed with acid-alcohol (5% acetic in 95% ethanol) for 30 min and stained with 0.2% crystal violet made in 75% ethanol, and the plaques were counted. Rabbit anti-VSVIND serum, rabbit anti-VSVNJ serum, and rabbit anti-REV-T serum were prepared as described previously (7) . All the sera were heat inactivated at 56°C for 45 min before use.
bNT, Not tested.
ble on CEF cells. We also consistently found a higher proportion of pseudotype formation with VSVNJ and REV-T. To test the specificity of'
antiserum, neutralization experiments were performed. Anti-VSVIND 0 Anti-VSVNJ 7 .42 x 107 a Neutralization mixtures were made with equal volumes of virus and anti-REV-T, anti-VSVIND, or anti-VSVNJ rabbit serum. VSVIND was prepared in mouse L2 cells, and details of neutralization and plaque assay on CEF were identical to those described in footnote a, Table 1. tion experiments were performed. If progeny VSV, produced from the REV-T-producing CBM cells, contain a mixture of surface projections, characteristic of both REV-T and VSV, the neutralization of the infectivity using anti-VSV antiserum alone would be less sensitive than the neutralization of the infectivity of pure VSV when assayed on CEF cells. Thus, VSV with mixed surface projections would be neutralized slower with anti-VSV antiserum alone or anti-REV-T antiserum alone. As can be seen in Fig. la, anti-VSVINI anti-VSVIN,, antiserum is 2.46, whereas the slope of the neutralization of VSVINI) pseudotypes is 0.88. The anti-VSVIND antiserum can neutralize pure VSVINI) about 2.5 to 3 times more efficiently than the neutralization of the VSVIN,, pseudotype. We have also determined the kinetics of neutralization of the progeny VSVIND using both anti-REV-T antiserum and anti-VSVIND antiserum. If the progeny VSVIND were neutralized first with excess amounts of anti-REV-T antiserum to mask all of the REV-T antigens and then with varied concentrations of anti-VSVIND antiserum, the kinetics of neutralization should be the same as if we used the pure VSVIND. Figure la shows that the kinetics of neutralization by anti-VSVIND antiserum of VSVIND pseudotype, which has been neutralized with anti-REV-T antiserum, are similar to the kinetics of the pure VSVIND (slope of 2.3).
Another approach for demonstrating the mixed envelope components of the VSV pseudotypes is to use host cells restrictive for REV instead of anti-REV antiserum. To find a restricted host of REV, we infected NRK cells with the VSVIND pseudotypes after neutraliza- tion of the virus with anti-VSVIND antiserum. It is evident that the VSVIND pseudotype consisting of coat antigens resistant to the anti-VSVIND antiserum, which must be the REV coat antigens, did not produce any plaques on NRK cells (Table 3) . Accordingly, we can conclude that NRK cells do not support the initial steps of REV infections; presumably, they block infec-tion at the level of attachment and penetration. 
